Non-Surgical Locoregional Therapies Alone or in Combination with Systemic Therapy in Patients with Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the most common primary liver cancer, representing the third-leading cause of cancer-related deaths worldwide. Curative intent treatment options for patients with HCC include liver transplantation, resection and ablation of small lesions. Other potentially curative...
Main Authors: | Perla Chami, William Jarnagin, Ghassan K. Abou-Alfa, James Harding, Neal Kim, Haibo Lin, Maria El Homsi, Christopher Crane, Carla Hajj |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/6/1748 |
Similar Items
-
Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies
by: Mina S. Makary, et al.
Published: (2020-07-01) -
Locoregional Therapy for Intrahepatic Cholangiocarcinoma
by: Mackenzie Owen, et al.
Published: (2023-04-01) -
New Insights on Liver-Directed Therapies in Hepatocellular Carcinoma
by: Christina G. Dalzell, et al.
Published: (2023-12-01) -
Locoregional Therapies for Hepatobiliary Tumors: Contemporary Strategies and Novel Applications
by: Andrei M. Jipa, et al.
Published: (2024-03-01) -
Friend or Foe? Locoregional Therapies and Immunotherapies in the Current Hepatocellular Treatment Landscape
by: Shamar Young, et al.
Published: (2023-07-01)